Interview with Biologics Course Chair,
Wellington Hsu, MD
How did the biologics course
come about as
an add-on to
The annual biolog-
What makes this course worth
ics review course
first started six
years ago as part
of the Resources for Medical Education
Collaborative society meeting. At this
time, the spine surgery arena needed a
forum to speak about the efficacy, safety
and regulatory aspects of orthobiolog-
ics in light of brewing controversies
involving growth factor and stem cell
use. Last year was the first with NASS as
a sponsor as a Spine Foundation course
in February. Based on its enormous suc-
cess for both industry and attendees, we
decided to capitalize on the momentum
and to draw health care practitioners
from the loyal following of the Summer
Spine meeting for this year's program.
taking an extra day away from
practice for spine care providers?
This course will allow academicians, sur-
What information from the
geons, scientists and industry partners
to exchange dialog regarding the present
and future landscape of spinal biologics.
This is a rapidly changing field that
requires understanding and communi-
cation to address the critical issues. In
the past, this type of forum led to discus-
sion of biologics-related complications
before they were published, which
allowed surgeons to stay ahead of the
game when it came to decision-making
course will spine care providers
be able to use in their practices
when they go home?
Not only will there be scientific lectures on the mechanisms of product
categories and the differences between
products, but there will also be debates
highlighting advantages and disadvantages of the use of particular spinal
biologics and structural cages.
What is your main “can’t miss”
session in this course?
We will have an "On the Horizon" session where leading surgeon-scientists
will share the technologies they are
investigating and how they will change
the future of spinal biologics.
How will Bioventus’ involvement
as the principal sponsor en-
hance the course?
Bioventus has positioned itself as a
leader in the spinal biologics space
by providing a multitude of products
in different categories for a variety of
conditions for surgeons. Their support
as the principal sponsor of this course
validates the messages and content that
this course hopes to convey.
What are the goals of the
Section on Biologics?
Our goals are to provide NASS members
with educational content regarding not
only orthobiologics but also other areas
of basic research such as infection control, clinical outcomes and degenerative
Why is staying abreast of new
biologics technology important
to anyone practicing in the
spine care field?
This is such a rapidly changing field that
spine care practitioners can quickly find
themselves using antiquated products
and procedures for spine fusion. Hearing about the issues regarding biologics
will help prevent that.
Can you preview any of the
Section on Biologics’ content at
the upcoming Annual Meeting?
The Section on Biologics has a rich
offering as part of the upcoming Annual
Meeting including symposia involving
structural interbody cages, infection
control with topical agents, and the
review of the latest evidence for mesenchymal stem cells.
BIOLOGICS INTERVENTIONS FOR SPINAL
PATHOLOGIES: STEM CELLS, GROWTH FACTORS
AND NOVEL THERAPEUTICS
Wednesday, July 26 | 7: 30 AM - 3: 45 PM
Sheraton San Diego Hotel & Marina
Purchase with a summer spine registration and save $150!
Course is only $200 with this discount.
Visit www.summerspine.org for more information.